What is NDC 58602-721?

58602-721 is the product NDC for Athentia Next (levonorgestrel), Levonorgestrel 1.5 mg/1 tablet, listed with the FDA by Aurohealth LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Athentia Next (Levonorgestrel).

Aurohealth LLC, NDC labeler code 58602. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Athentia Next?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Athentia Next NDC 58602-721 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)58602-721Labeler and product segments. Claims need a package NDC.

Product NDC at billing width58602-0721Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
58602-721-57	5860207215758602072157	1 BLISTER PACK in 1 CARTON (58602-721-57) / 1 TABLET in 1 BLISTER PACKMarketed from Dec 8, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Athentia Next
Generic name (nonproprietary): levonorgestrel
Active ingredients: Levonorgestrel — 1.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Aurohealth LLCNDC labeler code 58602
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206867
Marketing start: Dec 8, 2015
Listing expires: Dec 31, 2027
Other FDA classes: Inhibit Ovum Fertilization (Physiologic effect)Progesterone Congeners (Chemical structure)Progesterone Congeners (Chemical structure)
Identifiers: Product ID 58602-721_37fd0173-d5cc-4fd2-8307-8b76fe39186eSPL ID 37fd0173-d5cc-4fd2-8307-8b76fe39186eSPL set ID 34e5aa53-3943-4e2f-93aa-b5a4d779a703RxCUI 483325UNII 5W7SIA7YZW
Pharmacologic class: Progestin; Progestin-containing Intrauterine System

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N458602072157 followed by a unit qualifier and the quantity

Package 58602-0721-57. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 4, 2025.

Indications (excerpt from the label)

Use for women to reduce chance of pregnancy after unprotected sex (if a contraceptive failed or if you did not use birth control)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 58602-721

What is NDC 58602-721?: 58602-721 is the product NDC for Athentia Next (levonorgestrel), Levonorgestrel 1.5 mg/1 tablet, listed with the FDA by Aurohealth LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Athentia Next (Levonorgestrel).
What is the active ingredient?: Levonorgestrel.
Who is the labeler?: Aurohealth LLC, NDC labeler code 58602. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Athentia Next?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 206867

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206867
Product	Strength	Form · route	Labeler	Product NDC
After Bangerlevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Aurohealth LLC	58602-891
Amazon Basic Care Levonorgestrellevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Amazon.com Services LLC	72288-324
Econ Morning Afterlevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Aurohealth LLC	58602-841
EContra One-Steplevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Afaxys Pharma, LLC	50102-211
Fem Choice morning afterlevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Aurohealth LLC	58602-712
Ithappenz Morning Afterlevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Aurohealth LLC	58602-892
Julielevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Julie Products Inc.	82791-532
Julielevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Julie Products Inc.	82791-538
Julie Morning After Pilllevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Julie Products Inc.	82791-002
Julie Morning After Pilllevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Julie Products Inc.	82791-003
Julie Morning After Pilllevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Julie Products Inc.	82791-004
Levonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Rugby Laboratories	0536-1433
Levonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	LEADER/ CARDINAL HEALTH 110, INC.	70000-0675
Morning Afterlevonorgestrel	Levonorgestrel 1.5 mg/1.5mg	TabletOral	Rapha Pharmaceuticals, Inc.	69953-515

Athentia Next (Levonorgestrel) NDC 58602-721